At ECTRIMS, we presented our latest advancements in Multiple Sclerosis (MS).
Here is the video of our presentation:
Download the ECTRIMS 2024 presentation slides
Our Healthcare Program Director, Damien Eggenspieler, and Healthcare Partnerships Lead, Yacine Bechichi attended the conference.
Wearables and digital health technologies are transforming how we capture real-world outcomes in clinical trials. However, moving to full-scale execution presents significant operational, logistical, and
For years, clinical trials in achondroplasia have relied heavily on annual growth velocity as the primary outcome measure. However, height alone doesn’t tell the full
In July 2023, the European Medicines Agency (EMA) granted qualification to SV95C (Stride Velocity 95th Centile) as a primary endpoint for clinical trials in ambulatory
